Restriction analysis of replication products. (A) Transient-replication assay of vector constructs with promoters of different strengths driving E1 expression (SRα, RSV, TK) and with two ori locations (in HindIII or in XhoI sites). After transfection of 1 and 2 μg of vector DNA into CHO cells, episomal replication products were isolated, purified, and analyzed 72 h posttransfection using DpnI and different enzyme combinations: HindIII (lanes 2 and 3), MunI/Eco47III (lanes 5, 6, 11, 12, 14, 15, 17, and 18), and MunI/Eco47III/HindIII (lanes 8 and 9). Lanes 1, 4, 7, 10, 13, and 16 contain markers for the input plasmids, cleaved with respective enzymes. (B to D) Analysis of replication products in plasmids with high-level E1 expression (construct SRE1HO) in the CHO cell line, using 1.0 μg of transfected DNA. The cells were harvested 48, 72, and 96 h after transfection, and low-molecular-weight DNA was analyzed on 0.8% agarose gel by Southern blotting. DNA was digested with DpnI and additionally with the linearizing enzyme EcoRI (panel B, lanes 2 to 4); with enzyme HindIII (panel B, lanes 6 to 8), which cleaves out the origin-containing fragment (arrow); or with the enzyme combinations HindIII/XbaI (C) and HindIII/BglII (D). ori-sequence containing bands are shown by arrows. Marker DNAs (400 pg), digested with respective enzymes, are also shown. The blots were exposed for 24 h. (E) Schematic representation of amplification of SRE1HO vector. 32P-labeled dCTP incorporation was normalized to that based on the length of restriction fragments. The number of copies of origin sequence-containing fragments synthesized was calculated by comparing the incorporation of labeled nucleotides in the origin sequence-containing fragment to the incorporation of label into other fragments generated by the enzyme cleavage. A schematic representation of the linearized SRE1HO construct is shown below the graph, where viral origin, coding sequences, promoters, and used restriction enzyme cleavage sites are presented. Ori fr., origin sequence-containing fragment.